Skip to menu Skip to content Skip to footer

1990

Journal Article

How nephrotoxic is carboplatin?

Hardy, J. R., Tan, S., Fryatt, I. and Wiltshaw, E. (1990). How nephrotoxic is carboplatin?. British Journal of Cancer, 61 (4), 644-644. doi: 10.1038/bjc.1990.143

How nephrotoxic is carboplatin?

1990

Conference Publication

Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac)

Jones, A. L., Powles, T. J., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1990). Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac). 31st annual meeting of the British Association of Cancer Research and the 5th annual meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. BASINGSTOKE: STOCKTON PRESS. doi: 10.1038/bjc.1990.324

Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac)

1990

Journal Article

Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer

Hardy, JR, Powles, TJ, Judson, IR, Sinnett, HD, Ashley, SE, Coombes, RC and Ellin, CL (1990). Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer. European Journal of Cancer, 26 (7), 824-827. doi: 10.1016/0277-5379(90)90162-M

Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer

1990

Conference Publication

Dose intensity in ovarian-cancer

Hardy, J. R., Hryniuk, W. M. and Wiltshaw, E. (1990). Dose intensity in ovarian-cancer. 31st Annual Meeting of the British Association of Cancer Research and the 5th Annual Meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bjc.1990.324

Dose intensity in ovarian-cancer

1989

Journal Article

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

Hardy, J. R., Noble, T. and Smith, I. E. (1989). Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. British Journal of Cancer, 60 (5), 764-766. doi: 10.1038/bjc.1989.355

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

1989

Journal Article

Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid

Olliff, Jfc, Hardy, JR, Williams, MP and Powles, TJ (1989). Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid. Clinical Radiology, 40 (6), 632-633. doi: 10.1016/S0009-9260(89)80329-0

Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid

1989

Journal Article

Chemoprevention of Breast-Cancer

Powles, TJ, Hardy, JR, Ashley, SE, Cosgrove, D, Davey, JB, Dowsett, M, McKinna, A, Nash, AG, Rundle, SK, Sinnett, HD, Tillyer, CR and Treleaven, JG (1989). Chemoprevention of Breast-Cancer. Breast Cancer Research and Treatment, 14 (1), 23-31. doi: 10.1007/BF01805972

Chemoprevention of Breast-Cancer

1989

Journal Article

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

Powles, T. J., Hardy, J. R., Ashley, S. E., Farrington, G. M., Cosgrove, D., Davey, J. B., Dowsett, M., McKinna, J. A., Nash, A. G., Sinnett, H. D., Tillyer, C. R. and Treleaven, J. G. (1989). A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. British Journal of Cancer, 60 (1), 126-131. doi: 10.1038/bjc.1989.235

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

1989

Journal Article

Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy

Hardy, JR and Harvey, VJ (1989). Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy. Gynecologic Oncology, 33 (3), 296-300. doi: 10.1016/0090-8258(89)90515-5

Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy

1989

Conference Publication

The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study

Evans, PC, Hardy, JR, Paxton, JW, Harvey, VJ and Baguley, BC (1989). The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study. WELLINGTON: NEW ZEALAND MED ASSN.

The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study

1989

Conference Publication

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

Lonning, PE, Dowsett, M, Jacobs, S, Schem, B, Hardy, J and Powles, TJ (1989). Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women. 9th International Symp of the Journal of Steroid Biochemistry : Recent Advances in Steroid Biochemistry, Las Palmas Gran Canaria Spain, May 28-31, 1989. doi: 10.1016/0022-4731(89)90143-X

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

1989

Journal Article

The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit

Paxton, JW, Evans, PC and Hardy, JR (1989). The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit. Cancer Chemotherapy and Pharmacology, 23 (5), 291-295. doi: 10.1007/BF00292406

The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit

1988

Journal Article

Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)

Hardy, JR, Harvey, VJ, Paxton, JW, Evans, P, Smith, S, Grove, W, Grillolopez, AJ and Baguley, BC (1988). Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921). Cancer Research, 48 (22), 6593-6596.

Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)

1988

Journal Article

The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial

Paxton, JW, Hardy, JR, Evans, PC, Harvey, VJ and Baguley, BC (1988). The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial. Cancer Chemotherapy and Pharmacology, 22 (3), 235-240. doi: 10.1007/BF00273417

The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial

1987

Journal Article

The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy

Hardy, JR, Maclean, GD, Foote, GA and Harvey, VJ (1987). The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy. Australian & New Zealand Journal of Obstetrics & Gynaecology, 27 (2), 146-149. doi: 10.1111/j.1479-828X.1987.tb00967.x

The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy